Skip to main content

Table 4 Characteristics of patients with COVID-19 who died (n = 12) within 30 days and patients who survived (n = 98) for 30 days

From: “Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”

30-day outcome

P (Chi-square analysis)

  

Survived

Deceased

  

Count

%

Count

%

Age (years)

Lowk

53

54

3

25

0.057

(median)

Highl

45

46

9

75

 

Creatinine (µmol/l)

(median)

Low

56

57

3

25

 < 0.05

High

42

43

9

75

eGFRa (ml/min/1.73m2)

median

Low

47

48

9

75

0.077

High

51

52

3

25

WBCb count (x10i/l)

(median)

Low

53

54

1

8

 < 0.01

High

45

46

11

92

Neutrophil count (x10i/l)

(median)

Low

48

49

1

8

 < 0.01

High

50

51

11

92

Lymphocyte count (x10i/l)

(median)

Low

42

43

9

75

 < 0.05

High

56

57

3

25

NLRc

(median)

Low

48

49

0

0

 = 0.001

High

50

51

12

100

CRPd (mg/l)

(median)

Low

53

54

1

8

 < 0.01

High

45

46

11

92

B cell modulation

 BAFFe (pg/ml)

(median)

Low

53

54

2

17

 < 0.05

High

45

46

10

83

 IL-4f (pg/ml)

(median)

Low

51

52

4

33

NS

High

47

48

8

67

 IFN-αg (pg/ml)

(median)

Low

52

53

2

17

 < 0.05

High

46

47

10

83

T cell modulation

 sCD25h/IL-2Rαi (pg/ml)

(median)

Low

53

54

2

17

 < 0.05

High

45

46

10

83

 sCD40L (pg/ml)

(median)

Low

51

52

4

33

NS

High

47

48

8

67

 sPD-L1j (pg/ml)

(median)

Low

52

53

3

25

0.067

High

46

47

9

75

 sCD95/Fas (pg/ml)

(median)

Low

52

53

3

25

0.067

High

46

47

9

75

  1. a Estimated glomerular filtration rate
  2. b White blood cells
  3. c Neutrophil-leukocyte ratio
  4. d C-reactive protein
  5. e B-cell activating factor
  6. f Interleukin 4
  7. g Interferon-α
  8. h Soluble cluster of differentiation 25
  9. i Interleukin 2 receptor- α
  10. j Soluble programmed death-ligand 1
  11. k Low: lower than median. l High: higher than median